Gradient Investments LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1542265 ARDEN HILLS, MN

Position in HALO

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$1,286,523

New position

Shares Held

16,437

first reported quarter

Ownership

0.014%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#286

of 664 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Gradient Investments LLC holds $2,903,408 across 4 Biotechnology names. HALO ranks #1 (44.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc. This page	16,437	$1,286,523
2	ACAD	Acadia Pharmaceuticals Inc	32,738	$828,271
3	REGN	Regeneron Pharmaceuticals, Inc.	827	$515,667
4	ORKA	Oruka Therapeutics, Inc.	2,868	$272,947

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,286,523	16,437	—	Shares	Sole	2026-07-08
No filing history on record for this holder in this stock.